申请人:Laboratorios Almirall, S.A.
公开号:US07855202B2
公开(公告)日:2010-12-21
The present disclosure relates to imidazopyridine derivatives of formula (I):
The present disclosure also relates to a method for treating a subject afflicted with a pathological condition or disease susceptible to amelioration by antagonism of the A2B adenosine receptor.
本公开涉及式(I)的咪唑吡啶衍生物。本公开还涉及一种治疗由于A2B腺苷受体拮抗而可缓解的病理状态或疾病的方法。